Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis

Background: Imaging of subclinical atherosclerosis improves cardiovascular risk prediction on top of traditional risk factors. However, cardiovascular imaging is not universally available. This work aims to identify circulating proteins that could predict subclinical atherosclerosis. Methods: Hypoth...

ver descrição completa

Detalhes bibliográficos
Autores: Nuñez, Estefania|||0000-0002-0876-1264, Fuster, Valentín, Gómez-Serrano, María, Valdivielso, José Manuel|||0000-0003-1343-0184, Fernández-Alvira, Juan Miguel, Martínez-López, Diego, Rodríguez, José Manuel, Bonzon-Kulichenko, Elena|||0000-0003-0852-7520, Calvo, Enrique, Alfayate, Alvaro, Bermúdez-López, Marcelino|||0000-0002-3188-4158, Escolà-Gil, Joan Carles|||0000-0001-9021-2485, Fernández-Friera, Leticia, Cerro-Pardo, Isabel|||0000-0002-2542-5051, Mendiguren, José María, Sánchez-Cabo, Fátima|||0000-0003-1881-1664, Sanz Salvo, Javier, Ordovás, José María, Blanco-Colio, Luis Miguel|||0000-0002-1560-6609, García-Ruiz, José Manuel, Ibañez, Borja|||0000-0002-5036-254X, Lara-Pezzi, Enrique, Fernández-Ortiz, Antonio, Martín-Ventura, José Luis, Vázquez, Jesús|||0000-0003-1461-5092
Formato: artículo
Fecha de publicación:2022
País:España
Recursos:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:284185
Acesso em linha:https://ddd.uab.cat/record/284185
https://dx.doi.org/urn:doi:10.1016/j.ebiom.2022.103874
Access Level:acceso abierto
Palavra-chave:Subclinical atherosclerosis
Proteomics
Biomarkers
IGHA2
APOA
HPT
Descrição
Resumo:Background: Imaging of subclinical atherosclerosis improves cardiovascular risk prediction on top of traditional risk factors. However, cardiovascular imaging is not universally available. This work aims to identify circulating proteins that could predict subclinical atherosclerosis. Methods: Hypothesis-free proteomics was used to analyze plasma from 444 subjects from PESA cohort study (222 with extensive atherosclerosis on imaging, and 222 matched controls) at two timepoints (three years apart) for discovery, and from 350 subjects from AWHS cohort study (175 subjects with extensive atherosclerosis on imaging and 175 matched controls) for external validation. A selected three-protein panel was further validated by immunoturbidimetry in the AWHS population and in 2999 subjects from ILERVAS cohort study. Findings: PIGR, IGHA2, APOA, HPT and HEP2 were associated with subclinical atherosclerosis independently from traditional risk factors at both timepoints in the discovery and validation cohorts. Multivariate analysis rendered a potential three-protein biomarker panel, including IGHA2, APOA and HPT. Immunoturbidimetry confirmed the independent associations of these three proteins with subclinical atherosclerosis in AWHS and ILERVAS. A machine-learning model with these three proteins was able to predict subclinical atherosclerosis in ILERVAS (AUC [95%CI]:0.73 [0.70-0.74], p < 1 × 10), and also in the subpopulation of individuals with low cardiovascular risk according to FHS 10-year score (0.71 [0.69-0.73], p < 1 × 10). Interpretation: Plasma levels of IGHA2, APOA and HPT are associated with subclinical atherosclerosis independently of traditional risk factors and offers potential to predict this disease. The panel could improve primary prevention strategies in areas where imaging is not available.

Registos relacionados